Sun Pharma gets rights to sell bad cholesterol drug in ex-US markets
Sun Pharmaceutical Industries has signed an exclusive licensing agreement with LIB Therapeutics to commercialise and manufacture lerodalcibep, a drug for lowering LDL or bad cholesterol, in markets outside the US and China.…
Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.